Abstract
The only strategy to select individuals at increased risk for type 1 diabetes for primary prevention trials is through genetic risk assessment. While genome-wide association studies have identified more than 40 loci associated with type 1 diabetes, the single most important genetic determinants lie within the human leucocyte antigen gene family on chromosome 6.
In this chapter we describe a protocol for a straightforward, cheap strategy to determine HLA class II mediated risk of type 1 diabetes. This method has proved robust for genotyping whole-genome-amplified DNA as well as DNA extracted directly from human tissues.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nerup J, Platz P, Andersen OO et al (1974) HL-A antigens and diabetes mellitus. Lancet 2:864–866
Cudworth AG, Woodrow JC (1975) Evidence for HL-A-linked genes in ‘juvenile’ diabetes mellitus. Br Med J 3:133–135
Todd JA, Bell JI, McDevitt HO (1987) HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599–604
Caillat-Zucman S, Garchon HJ, Timsit J, Assan R, Boitard C, Djilali-Saiah I, Bougnères P, Bach JF (1992) Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest 90:2242–2250
Gillespie KM, Gale EA, Bingley PJ (2002) High familial risk and genetic susceptibility in early-onset childhood diabetes. Diabetes 51:210–214
Gillespie KM, Aitken RJ, Wilson I et al (2014) Early onset of diabetes in the proband is the major determinant of risk in HLA DR3-DQ2/DR4-DQ8 siblings. Diabetes 63:1041–1047
Lambert AP, Gillespie KM, Thomson G et al (2004) Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. J Clin Endocrinol Metab 89:4037–4043
Bunce M, O’Neill CM, Barnardo MC et al (1995) Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 46:355–367
Acknowledgement
This work was supported by Diabetes UK grants to KMG.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Aitken, R.J., Mortimer, G.L., Gillespie, K.M. (2015). Type 1 Diabetes High-Risk HLA Class II Determination by Polymerase Chain Reaction Sequence-Specific Primers. In: Gillespie, K. (eds) Type-1 Diabetes. Methods in Molecular Biology, vol 1433. Humana Press, New York, NY. https://doi.org/10.1007/7651_2015_307
Download citation
DOI: https://doi.org/10.1007/7651_2015_307
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3641-0
Online ISBN: 978-1-4939-3643-4
eBook Packages: Springer Protocols